Abiopharma

🔍 Krouse George R Jr (Executive)

Company: SBA COMMUNICATIONS CORP (SBAC)

Report Date: 2026-08-17

Detailed Transactions and Holdings:

• Sold 300 shares of Class A Common Stock at $182.6745 per share (Direct)
  Date: 2026-08-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 8,511.64 | transaction_form_type: 4 | Footnotes: F1
• Holds 302 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: H | shares_owned_after: 302.00 | Footnotes: F2, F3, F3
• Holds 663 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: H | shares_owned_after: 663.00 | Footnotes: F2, F4, F4
• Holds 1,108 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-17 | Code: H | shares_owned_after: 1,108.00 | Footnotes: F2, F5, F5

Footnotes:

• F1: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $182.49 to $182.78 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security hold of the issuer full information regarding the number of shares sold at each separate price.
• F2: Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock.
• F3: These restricted stock units vest in accordance with the following schedule: 302 vested on May 1, 2025; 302 vested on May 2026; and 302 vest on May 1, 2027.
• F4: These restricted stock units vest in accordance with the following schedule: 331 vested on May 1, 2026; 331 vest on May 1, 2027; and 332 vest on May 1, 2028.
• F5: These restricted stock units vest in accordance with the following schedule: 369 vest on May 1, 2027; 369 vest on May 1, 2028; and 370 vest on May 1, 2029.